Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
Journal of the Pediatric Infectious Diseases Society|February 2, 2026
Safety, Reactogenicity, and Acceptability of a Placebo Dissolving Microneedle Patch in ChildrenCarol M Kao, Christina A Rostad, Peggy Kettle, et al.
Blood|August 16, 2011
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in miceAndrea U Steinbicker, Thomas B Bartnikas, Lisa K Lohmeyer, et al.
Nitric Oxide : Biology and Chemistry|June 7, 2011
Nitric oxide regulates pulmonary vascular smooth muscle cell expression of the inducible cAMP early repressor geneAndrea U Steinbicker, Heling Liu, Kim Jiramongkolchai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2021
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in ChildrenInci Yildirim, Carol M Kao, Ashley Tippett, et al.
Nature|July 31, 2015
Magnetospherically driven optical and radio aurorae at the end of the stellar main sequenceG Hallinan, S P Littlefair, G Cotter, et al.
Blood|February 7, 2014
The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6Claire Mayeur, Lisa K Lohmeyer, Patricio Leyton, et al.
Leukemia|October 31, 2013
Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibitionH M Mehta, M Futami, T Glaubach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 2, 2024
Examining Clinical Features and Severe Neurologic Disease of Parechovirus Infection in Young Infants: A Multistate Cohort StudyAmanda S Evans, Sumit Singh, Charuta Joshi, et al.
The Pediatric Infectious Disease Journal|October 20, 2023
Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021Ami B Shah, Joseph Y Abrams, Shana Godfred-Cato, et al.
The Journal of Infectious Diseases|March 27, 2024
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US AdultsCarol M Kao, Christina A Rostad, Lauren E Nolan, et al.
Pageof 28